Understanding Pyruvate Kinase Deficiency (PKD) & Hemolytic Anemia

Receiving a diagnosis of Pyruvate Kinase Deficiency (PKD) can feel overwhelming, especially since it is a rare condition that many people—and even some doctors—have never heard of. It is important to know that while PKD is a lifelong condition, it is treatable, and having a clear diagnosis is the most critical step toward getting the right care ^[1][2].

What is Pyruvate Kinase Deficiency?

Pyruvate Kinase Deficiency is a rare, inherited blood disorder that causes hemolytic anemia—a condition where red blood cells break down faster than the body can replace them ^[2][3].

Specifically, PKD is the most common glycolytic enzyme deficiency causing non-spherocytic hemolytic anemia ^[1][4]. To understand this:

• Glycolytic enzyme: Red blood cells need an enzyme called pyruvate kinase to produce energy (ATP) through a process called glycolysis.
• Deficiency: In PKD, the red blood cells don’t have enough of this enzyme. Without it, they run out of energy, become fragile, and are destroyed prematurely ^[3][2].
• Non-spherocytic: This means the red blood cells do not take on a sphere shape (which happens in other types of anemia) but are still being destroyed ^[1].

How PKD Presents

The symptoms of PKD vary significantly from person to person. Even siblings with the same genetic mutations can have different experiences ^[5][6].

In Newborns (Neonates)

In babies, PKD often appears shortly after birth. Common signs include:

• Jaundice: A yellowing of the skin and eyes caused by the buildup of bilirubin as red blood cells break down. This is often treated initially with phototherapy (light therapy) ^[7][8].
• Severe Anemia: Babies may require blood transfusions early on to maintain healthy oxygen levels ^[1].
• Organ Enlargement: Doctors may notice hepatosplenomegaly (an enlarged liver and spleen) as these organs work harder to filter out damaged blood cells ^[9][10].

In Children and Adults

As patients grow, the body sometimes adapts to lower hemoglobin levels, but symptoms persist and may include:

• Chronic Fatigue: A persistent lack of energy that can affect school, work, and daily life ^[11].
• Gallstones: These can develop even in young children because the constant breakdown of red blood cells creates excess bilirubin, which forms stones in the gallbladder ^[7][2].
• Iron Overload: This is a major concern for all PKD patients. Even those who do not receive regular blood transfusions can accumulate too much iron, which can damage the liver and heart over time ^[7][12]. Important Warning: Never take over-the-counter iron supplements without explicit instruction from your hematologist.

Understanding the Diagnosis

PKD is an autosomal recessive disorder, meaning a child must inherit one altered gene from each parent to have the condition ^[1]. Because it is autosomal recessive, if you have PKD, your children will definitely be carriers of the gene. However, they will only inherit the disease itself if your partner is also a carrier or has PKD.

While doctors often start with an enzyme assay (a test to measure how much pyruvate kinase is active in the blood), this test can sometimes be inconclusive ^[13]. Genetic testing (such as Next-Generation Sequencing) is now considered the “gold standard” for confirming the diagnosis and identifying the specific mutations involved ^[13][14]. For more details, see The Biology and Diagnosis of PKD.

Daily Life and Family Planning

• Lifestyle Adaptations: If your spleen is enlarged, you should avoid contact sports to reduce the risk of a severe injury.
• Pregnancy: Pregnancy is absolutely possible, but because the demands on the body increase, it requires close, coordinated monitoring by both a high-risk obstetrician and your hematologist.

Stabilizing Facts for Families

• It is not your fault: PKD is a genetic condition; nothing you did caused this to happen.
• You are not alone: Though rare, there is a global community of patients, families, and expert hematologists dedicated to PKD research ^[15][16].
• Care is evolving: Management has moved beyond just “watching and waiting.” From supportive care like transfusions to new disease-modifying therapies (like the enzyme activator mitapivat for adults) and curative options like stem cell transplants, there are more tools available than ever before ^[17][18]. See Treating PKD: From Supportive Care to Disease-Modifying Therapies.
• Anemia is manageable: Many people with PKD lead full, active lives by working closely with a hematologist to monitor their blood counts and iron levels ^[11][19]. See Living with PKD: Long-Term Monitoring & Complications.